Global Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit Market Growth 2024-2030

Global Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit Market Growth 2024-2030

Vitamin D is an essential nutrient with an important physiological role in the positive regulation of calcium homeostasis. Serum levels of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 (collectively referred to as total 25-hydroxyvitamin D) are indicators of vitamin D nutritional status, and reports indicate that these two forms of vitamin D may be bioactive and bioavailable. has a difference. Studies have shown that low levels of 25-hydroxyvitamin D are associated with various diseases, such as osteomalacia in adults and rickets in children, tumors, autoimmune diseases, cardiovascular diseases, metabolic syndrome, etc. Therefore, the detection of vitamin D has been widely used clinically.

The global Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit market size is projected to grow from US$ 736 million in 2024 to US$ 1147 million in 2030; it is expected to grow at a CAGR of 7.7% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit Industry Forecast” looks at past sales and reviews total world Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit sales for 2024 through 2030. With Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit industry.

This Insight Report provides a comprehensive analysis of the global Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit.

United States market for Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit players cover Abcam, Enzo Life Sciences, IDS Plc, Creative Diagnostics, Epitope Diagnostics Inc. (EDI), etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Detection Method: Fluorescence Immunochromatography
Detection Method: Colloidal Gold Method
Other

Segmentation by Application:
25-Hydroxyvitamin D2 Test
25-Hydroxyvitamin D3 Test

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abcam
Enzo Life Sciences
IDS Plc
Creative Diagnostics
Epitope Diagnostics Inc. (EDI)
SCIEX
Beijing BGI-GBI Biotech
Beijing Strong Biotechnologies,Inc.
Metware Biotechnology Inc (Metware)
Chromai
Shenzhen Sekbio
Nanjing Lansion
Shandong Maitian Biotechnology
Shandong Yingsheng Biology
Guangzhou Phicon
Shanghai Reigncom Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit market?

What factors are driving Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit market opportunities vary by end market size?

How does Human 25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.